GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.440
-0.050 (-1.11%)
At close: Dec 20, 2024, 4:00 PM
4.519
+0.079 (1.78%)
After-hours: Dec 20, 2024, 6:33 PM EST

Company Description

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.

It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.

The company was founded in 2011 and is headquartered in Santa Monica, California.

GoodRx Holdings, Inc.
GoodRx Holdings logo
Country United States
Founded 2011
IPO Date Sep 23, 2020
Industry Health Information Services
Sector Healthcare
Employees 694
CEO Scott Wagner

Contact Details

Address:
2701 Olympic Boulevard
Santa Monica, California 90404
United States
Phone 855 268 2822
Website goodrx.com

Stock Details

Ticker Symbol GDRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $33.00
CIK Code 0001809519
CUSIP Number 38246G108
ISIN Number US38246G1085
Employer ID 47-5104396
SIC Code 7374

Key Executives

Name Position
Scott W. Wagner Interim Chief Executive Officer and Principal Operating Officer
Trevor Bezdek Co-founder and Chairman of the Board
Douglas Joseph Hirsch Co-founder, Chief Mission Officer and Director
Karsten Ian Voermann Chief Financial Officer
Romin Nabiey Chief Accounting Officer
Bansi Nagji President of Healthcare
Mike Walsh President and Executive Vice President of Prescription Marketplace
Nitin Shingate Chief Technology Officer
Aubrey Reynolds Director of Investor Relations
Gracye Cheng General Counsel and Secretary

Latest SEC Filings

Date Type Title
Dec 18, 2024 SCHEDULE 13D/A Filing
Dec 18, 2024 SCHEDULE 13D/A Filing
Dec 16, 2024 8-K Current Report
Dec 2, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 10-Q Quarterly Report
Nov 7, 2024 8-K Current Report
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals